Cardiff Oncology Inc. buy Global_Player
Start price
17.11.22
/
50%
€1.24
Target price
17.11.23
-
Performance (%)
0.48%
End price
26.12.22
€1.25
Summary
This prediction ended on 26.12.22 with a price of €1.25. During the runtime of the prediction for Cardiff Oncology Inc. the price only changed by 0.48%. Global_Player has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Cardiff Oncology Inc. | 9.249% | 9.249% | 149.694% |
iShares Core DAX® | 0.000% | -2.064% | 13.111% |
iShares Nasdaq 100 | 0.626% | -2.884% | 37.744% |
iShares Nikkei 225® | 1.568% | -5.892% | 19.592% |
iShares S&P 500 | 0.334% | -2.281% | 27.745% |
According to Global_Player what are the pros and cons of Cardiff Oncology Inc. for the foreseeable future?
Pros
Cons
Risky Investment
Comments by Global_Player for this prediction
In the thread Trovagene diskutieren
Buy Cardiff Oncology Inc.
In the thread Trading Trovagene
Buy beendet
Stopped prediction by Global_Player for Cardiff Oncology Inc.
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€3.73
25.04.24
25.04.24
-
25.04.25
25.04.25
0.80%
27.04.24
27.04.24
Risky Investment
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.65
18.09.22
18.09.22
-
18.09.23
18.09.23
-3.77%
01.10.22
01.10.22
Risky Investment
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€6.00
17.01.22
17.01.22
-
17.01.23
17.01.23
-44.67%
22.01.22
22.01.22
Risky Investment
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€6.70
31.08.20
31.08.20
€6.00
03.09.20
03.09.20
-11.94%
03.09.20
03.09.20
Risky Investment